Reductions in [3H]nicotinic acetylcholine binding in Alzheimer’s disease and Parkinson’s disease: An autoradiographic study

Neurology

Volumn 38, Issue 5, 1988, Pages 720-723

  Whitehouse, P J ^a   Martino, A M ^c   Wagster, M V ^b   Price, D L ^b   Mayeux, R ^d   Atack, J R ^e   Kellar, K J ^f  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e and Kidney Diseases   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CARBACHOL; NICOTINIC RECEPTOR; RADIOISOTOPE; DIAGNOSTIC AGENT; TRITIUM;

ADULT; ALZHEIMER DISEASE; AUTOPSY; BRAIN CORTEX; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; AGED; AGING; ARTICLE; AUTORADIOGRAPHY; CADAVER; FRONTAL LOBE; METABOLISM;

AGED; AGING; ALZHEIMER DISEASE; AUTORADIOGRAPHY; CEREBRAL CORTEX; FRONTAL LOBE; HUMAN; PARKINSON DISEASE; POSTMORTEM CHANGES; RECEPTORS, NICOTINIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRITIUM;

EID: 0023818217     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.5.720     Document Type: Article

References (49)

1. Bowen DM, Smith CB, White P, Davison AN. Neurotransmitterrelated enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976;99:459–496.
2. Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer senile dementia. Nature 1976;288:279–280.
3. Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE. A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neurosci Lett 1977;6:85–89.
4. Ruberg M, Ploska A, Javoy-Agid F, Agid Y. Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to dementia. Brain Res 1982;232:129–139.
5. Arendt T, Bigl V, Arendt A, Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans, and Korsakoff’s disease. Acta Neuropathol (Bed) 1983;61:101–108.
6. Candy JM, Perry RH, Perry EK, et al. Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s diseases. J Neurol Sci 1983;59:277–289.
7. Tagliavini F, Pilleri C. Neuronal counts in basal nucleus of Meynert in Alzheimer disease and in simple senile dementia. Lancet 1983;1:469–470.
8. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981;10:122–126.
9. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237–1239.
10. Whitehouse PJ, Trifiletti RR, Jones BE, et al. Neurotransmitter receptor alterations in Huntington’s disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes. Ann Neurol 1985;18:202–210.
11. Nordberg A, Adolfsson R, Marcusson J, Winblad B. Cholinergic receptors in the hippocampus in normal aging and dementia of Alzheimer type. In: Giacobini E, Filogram G, Giacobini G, Vernadakis A, eds. The aging brain: cellular and molecular mechanisms of aging in the nervous system. Aging, vol 20. New York Raven Press, 1982:231–245.
12. Whitehouse PJ, Au KS. Neurotransmitter receptor alterations in Alzheimer’s disease. In: Traber J, Gispen WH, eds. Senile dementia of Alzheimer type. Berlin: Springer-Verlag, 1985:175–182.
13. Bowen DM, Spillane JA, Curzon G, et al. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet 1979;1:11–14.
14. Davies P, Verth AH. Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer’s type dementia brains. Brain Res 1978;138:385–392.
15. Greenamyre JT, Penney JB, Young AB, D’Amato CJ, Hicks SP, Shoulson I. Alterations in L-glutamate binding in Alzheimer’s and Huntington’s diseases. Science 1985;227:1496–1499.
16. Jenni-Eiermann S, vonHahn HP, Honegger CG, Ulrich J. Studies on neurotransmitter binding in senile dementia. Gerontology 1984;30:350–358.
17. Reisine TD, Yamamura HI, Bird ED, Spokes E, Enna SJ. Preand postsynaptic neurochemical alterations in Alzheimer’s disease. Brain Res 1978;159:477–481.
18. London ED, Waller SB. Relations between choline acetyltransferase and muscarinic binding in aging rodent brain and Alzheimer’s disease. In: Hanin I, ed. Dynamics of cholinergic function. Advances in behavioral biology, vol 30. New York: Plenum Press, 1986:215–224.
19. Nordberg A, Larsson C, Adolfsson R, Alafuzoff I, Winblad B. Muscarinic receptor compensation in hippocampus of Alzheimer patients. J Neural Transm 1983;56:13–19.
20. Mash DC, Flynn DD, Potter LT. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer’s disease and experimental cholinergic denervation. Science 1985;228:1115–1117.
21. Rinne JO, Rinne JK, Laaken K, Paijarvi L, Rinne UK. Reduction in muscarinic receptor binding in limbic areas of Alzheimer brain. J Neurol Neurosurg Psychiatry 1984;47:651–653.
22. Wood PL, Etienne P, Lal S, et al. A post-mortem comparison of the cortical cholinergic system in Alzheimer’s disease and Pick’s disease. J Neurol Sci 1983;62:211–217.
23. 3H]acetylcholine in rat brain. Mol Pharmacol 1982;22:56–62.
24. Marks MJ, Collins AC. Characterization of nicotine binding in mouse brain and comparison with the binding of a-bungamtoxin and quinuclidinyl benzilate. Mol Pharmacol 1982;22:554–564.
25. Romano C, Goldstein A. Stereospecific nicotine receptors on rat brain membranes. Science 1980;210:647–650.
26. Davies P, Feisullin S. Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain. Brain Res 1981;216:449–454.
27. Lang W, Henke H. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 1983;267:271–280
28. 18I]a-bungarotoxin. J Neurosci 1985;5:1307–1315.
29. Whitehouse PJ, Martino AM, Antuono PG, et al. Nicotinic acetylcholine binding in Alzheimer’s disease. Brain Res 1986;371:146–151.
30. Kuhar MJ. Receptor localization with the microscope. In: Yamamura HI, Enna SJ, Kuhar MJ, eds. Neurotransmitter receptor binding, 2nd ed. New York: Raven Press, 1985:153–176.
31. Kuhar MJ, Whitehouse PJ, Unnerstall JR, Hats H. Receptor autoradiography: analysis using a PC-baaed imaging system. Soc Neurosci Abstr 1984;10:558.
32. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 1986;72:115–119.
33. Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL. Muscarinic and nicotinic cholinergic binding sites in Alzheimer’s disease cerebral cortex. Brain Res 1987;436:62–68.
34. Amaducci L, Sorbi S, Albanese A, Gainotti G. Choline acetyltransferase (ChAT) activity differs in right and left human temporal lobes. Neurology 1981;31:799–805.
35. DeKosky ST, Scheff SW, Markesbery WR. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer’s disease and aging. Neurology 1985;35:1425–1431.
36. Mesulam MM, Mufson EJ, Levey AI, Wainer BH. Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque baaed on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience 1984;12:669–686.
37. Clarke PBS, Peh CB, Pert A. Autoradiographic distribution of nicotine receptors in rat brain. Brain Res 1984;323:390–395.
38. Lamour Y, Dutar P, Jobert A. Cortical projections of the nucleus of the diagonal band of Broca and of the substantia innominata in the rat: an anatomical study using the anterograde transport of a conjugate of wheat germ agglutinin and horseradish peroxidase. Neuroscience 1984;12:395–408.
39. Balfour DJK. The effects of nicotine on brain neurotransmitter systems. Pharmacol Ther 1982;16:269–282.
40. 3H]acetylcholine release from mouse cerebral cortical synaptosomes. J Neurochem 1984;43:1593–1598.
41. 3H]nicotine. J Neurochem 1985;45:604–610.
42. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimertype dementia. J Neurochem 1986;46:288–293.
43. 3H]acetylcholine on catecholamine and serotonin axons in brain. J Neurochem 1984;42:1495–1498.
44. Price DL, Whitehouse PJ, Struble RG. Cellular pathology in Alzheimer’s and Parkinson’s diseases. Trends Neurosci 1986;9:29–33.
45. Flood JF, Landry DW, Jarvik ME. Cholinergic receptor interactions and their effects on long-term memory processing. Brain Res 1981;215:177–185.
46. Wesnes K, Warburton DM. Effects of scopolamine and nicotine in human rapid information processing performance. Psychopharmacology 1984;82:147–150.
47. Gibson GE, Pelmas CJ, Peterson C. Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits. Pharmacol Biochem Behav 1983;18:909–916.
48. 3H]acetylcholine to nicotinic receptors. Neuropharmacology 1985;24:527–531.
49. Schwartz RD, Kellar KJ. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 1983;220:214–216.